(Press-News.org) The objective of “The Prevalence of Dementia in Europe 2025” report is to provide updated figures for the number of people living with dementia both for Europe as a whole, as well as the countries within.
It builds upon the work undertaken in the “Dementia in Europe Yearbook 2019”, in which Alzheimer Europe previously calculated the prevalence of dementia in Europe.
It applies prevalence estimates across 5-year age bands to UN World Population Prospects data 2024, for the years 2025 and 2050.
For 2025, there are an estimated 9,065,706 people with dementia living in EU27 countries and 12,122,979 for EU27 and non-EU countries combined.
For 2050, there will be an estimated 14,335,788 people with dementia in EU27 countries and 19,905,856 in EU and non-EU countries combined.
This means that, by 2050, the numbers are set to increase by 58% in the EU and by 64% across the whole of Europe.
The key message for EU and national decision-makers is that, with the number of people living with dementia increasing in this manner over the coming decades, they must act now, by investing sufficiently in health, care and social protection systems, providing adequate support for research, and implementing strong preventative interventions. Failure to do so can only exacerbate the challenges ahead.
Luxembourg, 28 January 2026 – Alzheimer Europe has today launched the “The Prevalence of Dementia in Europe 2025” report, which provides updated prevalence figures for the number of people living with dementia both for Europe as a whole, as well as the countries within. The report builds upon Alzheimer Europe’s previous work in the “Dementia in Europe Yearbook 2019”. Alzheimer Europe adopted the same methodology, seeking out community-based studies published since the Dementia in Europe Yearbook 2019, from which new prevalence rates across 5-year age bands were derived. These updated prevalence rates were then applied to population projections for 2025 and 2050 taken from the UN World Population Prospects (UN WPP) data 2024.
For 2025, the number of people living with dementia is 9,065,706 for EU27 countries and 12,122,979 for EU and non-EU countries. The report also estimates that by 2050 there will be 14,335,788 people with dementia in EU27 countries and 19,905,856 people with dementia in EU and non-EU countries combined. This means that, by 2050, the estimated number of people living with dementia will increase by 58% in the EU27 countries, and by 64% in EU and non-EU countries combined.
To understand whether there had been any significant change in the estimated number of people with dementia, between 2019 and 2025, Alzheimer Europe used its estimates for EU27 countries, as a point of comparison. The overall numbers of people estimated to be living with dementia in the EU27 for the years 2025 and 2050, are broadly consistent across the two reports. However, among men, consistently higher prevalence rates were observed in each of the 70+ age bands, but in particular for the 70-74 band. The picture for women was generally more mixed.
The projected increase in overall numbers reinforces the call that Alzheimer Europe and its member associations have been making for many years: EU and national decision-makers must take action to ensure that society supports people with the condition, their families and carers to live well as well as possible.
From a policy perspective, health and social care systems must have the necessary capacity and infrastructure to provide high-quality care and support to individuals living with dementia, from diagnosis through to end-of-life care.
Furthermore, research agendas must, as a matter of priority, give dementia the status it deserves, prioritising basic research to better understand the condition, clinical studies to develop diagnostics and treatments, and demographic research looking at the populations affected, allowing for improved system responses.
This report comes at a time when the future budget of the EU is being discussed and we can see that the proposals are moving away from the previous strong commitment to health, social affairs and research, and putting greater focus on defence and economic activities, under the scope of competitiveness.
Alzheimer Europe’s message for decision-makers at an EU and national level is clear: The number of people living with dementia will continue to grow over the coming decades. A failure to act now, to invest sufficiently in health, care and social protection systems, provide adequate support for research and implement strong preventative interventions, will exacerbate the challenges ahead.
Commenting on the publication of the report, Alzheimer Europe’s Executive Director, Jean Georges, stated:
“The scale of the challenge posed by dementia across Europe is substantial and it is our sincere hope that our updated figures provide the impetus for decision-makers, both at the European and national levels, to prioritise dementia and ensure it is addressed across the domains of health, research, disability policy and support for informal carers.
In particular, policy-makers must work to improve care services, make investments in health infrastructure for diagnosis and treatment, as well as help for family, carers and supporters of people with dementia. As part of this, they must take into consideration the changing demographics of the population and the prevalence of conditions such as dementia.
Our Helsinki Manifesto sets out a blueprint of actions, at the EU and national level, to improve the lives of people with dementia, their carers and families.
We reiterate the key calls from our Helsinki Manifesto: There is a clear need for a coordinated European Action Plan on Dementia and a dedicated research mission, each with ringfenced funding to ensure their proper implementation.”
The full report can be accessed on the website of Alzheimer Europe at: https://bit.ly/DementiaPrevalenceEurope2025
Interactive maps and graphs for countries across Europe, visualising the prevalence from 2025 to 2050, are available at: https://www.alzheimer-europe.org/dementia/prevalence-dementia-europe
For further information, contact: Jean Georges, Executive Director, Alzheimer Europe, 5B Heienhaff, L-1736 Senningerberg, Tel.: +352-29 79 70, Fax: +352-29 79 72, jean.georges@alzheimer-europe.org, www.alzheimer-europe.org
Notes to editors:
Alzheimer Europe is the umbrella organisation of national Alzheimer associations and currently has 41 member organisations in 36 European countries. The mission statement of the organisation is to change perceptions, practice and policy to ensure equal access of people with dementia to a high level of care services and treatment options.
The Prevalence of Dementia in Europe 2025 report received funding under an operating grant from the Citizens, Equality, Rights and Values programme. The views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the granting authority can be held responsible for them.
The Helsinki Manifesto was adopted at Alzheimer Europe’s Annual General Meeting on 16 October 2023, in Helsinki (Finland). It outlines the current position of dementia across Europe and lays the foundation for Alzheimer Europe’s campaigning activities from 2024-2029. The Manifesto is available at: https://www.alzheimer-europe.org/policy/campaign/alzheimer-europe-election-campaign-2024/helsinki-manifesto
END
New Alzheimer Europe report projects 64% increase in dementia across Europe by 2050
2026-01-28
ELSE PRESS RELEASES FROM THIS DATE:
How does TikTok shape young peoples' dietary preferences?
2026-01-28
Research in the International Journal of Consumer Studies reveals that TikTok functions as a powerful tool for shaping consumers' food preferences and behaviors through the use of algorithmic mechanisms, social influence, and users' emotional engagement.
The study, which was based on an online survey conducted in 2025 among 406 active TikTok users, found that the platform affects dietary preferences through various channels of influence.
"Nowadays, young people are aligning most of their dietary habits with the content they might see in social media,” said corresponding ...
Novel laser therapy device generates promising results in prostate cancer clinical trial
2026-01-28
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain patients. A clinical trial published in BJU International generated promising results for a type of focal therapy, which directly targets the cancer and spares the remainder of the unaffected prostate gland.
The ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT-PC) trial is the first pivotal trial of ProFocal®, a novel, cooled laser focal therapy device for prostate cancer treatment.
In the 100-participant trial, 84% of patients had no clinically significant prostate cancer on their ...
Does screen time affect teens’ sleep and lifestyle habits?
2026-01-28
New research in Brain & Behavior found a link between screen time and adolescents’ sleep quality and beliefs about healthy lifestyles.
In the study of 700 teens attending 2 high schools in the Black Sea region of Turkey, questionnaire responses revealed that participants who spent more time exposed to screens tended to have lower sleep quality. These adolescents were also less likely to have beliefs supporting the importance of maintaining a healthy lifestyle.
Screen exposure appeared to play a mediating role in the relationship between sleep quality ...
How do native and non-native plants affect endangered plant species in cities?
2026-01-28
Research in the Journal of Applied Ecology has identified threats to endangered plants in an urban area, generating information that can be used to guide effective conservation strategies across major cities.
For the study, investigators in Germany analyzed data on 1,231 populations of 201 endangered plant species within Berlin’s Flora Protection Program. Threats were categorized and their relative importance was quantified at both population and species levels, and across habitat types.
Biological threats—especially ...
Men’s heart attack risk climbs by mid-30s, years before women
2026-01-28
Men reached 5% cardiovascular disease risk about seven years earlier than women
Coronary heart disease drove most of the gap
Risk started diverging around age 35
Earlier risk in men suggests factors beyond smoking, hypertension and diabetes alone
CHICAGO --- Men begin developing coronary heart disease — which can lead to heart attacks — years earlier than women, with differences emerging as early as the mid-30s, according to a large, long-term study led by Northwestern Medicine.
The findings, based on more than three decades of patient follow-up, suggest that heart disease prevention and screening ...
New study signals major advance in the future of precision cancer care
2026-01-28
A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that a new computational method may help researchers identify effective precision treatments for cancer more quickly and efficiently.
Precision oncology is the promising, recently developed, approach to cancer treatment in which providers shape therapies to the unique molecular profile of a patient’s tumor. Current cancer therapy depends increasingly on matching the right drug to the right patient. Large-scale studies evaluate thousands of drugs on hundreds of cancer cell lines to find genetic biological markers to predict a drug’s effectiveness. In practice, however, this data is incredibly ...
Long COVID brain fog far more common in US than India, other nations
2026-01-28
Study of 3,100 patients is first to compare long COVID brain symptoms across continents
Brain fog affected 86% of non-hospitalized U.S. patients, compared with 15% in India
Symptom patterns clustered by income level, not geography
Disparities likely reflect culture and healthcare access, not a different virus
CHICAGO --- Patients with long COVID-19 in the U.S. report far higher rates of brain fog, depression and cognitive symptoms than patients in countries such as India and Nigeria, according to a large international study led ...
International differences exist in knowledge gaps and most common perimenopause symptoms
2026-01-28
CLEVELAND, Ohio (Jan 28, 2026)—Although perimenopause is experienced by all women regardless of race or nationality, it is not always experienced similarly. Studies comparing perimenopause symptoms across diverse cultures and geographic settings are lacking. A new study based on data from Flo, an international mobile health application, demonstrated inconsistency between perimenopause knowledge and actual symptoms experienced across diverse global populations. Study results are published online today in Menopause, the journal of The Menopause ...
Investigational blood biomarker panel may improve detection of pancreatic cancer
2026-01-28
Bottom Line: A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring CA19-9 levels alone.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
Author: Kenneth S. Zaret, PhD, professor at the Perelman School of Medicine at the University of Pennsylvania.
Background: ...
AAVLINK: Potent DNA-recombination method for large cargo delivery in gene therapy
2026-01-28
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying gene cargoes because of their superior gene segmentation flexibility and robust gene reconstitution efficiency. However, their limited packaging capacity is a major challenge for large gene transduction.
In a study published in Cell on Jan. 27, Prof. LU Zhonghua's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, and collaborators from Peking University First ...